Century Adds Biotech Veteran as Cell Therapies Near Milestones
PHILADELPHIA, PA — Century Therapeutics Inc. (Nasdaq: IPSC) appointed biotechnology executive Joseph Truitt to its board as the company prepares to move two cell-therapy programs toward regulatory and clinical milestones …
Century Adds Biotech Veteran as Cell Therapies Near Milestones Read More